Back to 
HBK INVESTMENTS L P
HBK INVESTMENTS L P
REGN
Showing 0 of 4 quarters
Position history for HBK INVESTMENTS L P's holdings in REGENERON PHARMACEUTICALS
No. HBK Investments exited its REGN (Regeneron Pharmaceuticals) position in Q1 2020. Its Q4 2019 13F listed 12,870 shares worth $4.8M. HBK Investments already held REGN in its Q1 2019 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.